Iterum Therapeutics PLC (ITRM)
NASDAQ
News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
The current ITRM market cap is 39.6M. The company's latest EPS is USD -0.6194 and P/E is -1.63.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -6.16M | -4.01M | -4.89M | -3.67M | -3.71M |
| Net Income | -7.1M | -5M | -6.09M | -6.58M | -4.89M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 553k | 195k | 503k | 82k | 0 |
| Operating Income | -31.57M | -24.34M | -29.12M | -47.39M | -18.7M |
| Net Income | -52.01M | -91.56M | -43.67M | -38.37M | -24.77M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 19.63M | 14.17M | 15.92M | 44.6M | 32.98M |
| Total Liabilities | 25.78M | 25.09M | 27.43M | 48.68M | 35.53M |
| Total Equity | -6.15M | -10.91M | -11.51M | -4.08M | -2.55M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 32.79M | 91.51M | 66.83M | 26.26M | 44.6M |
| Total Liabilities | 83.35M | 41.28M | 38.83M | 32.66M | 48.68M |
| Total Equity | -50.56M | 50.23M | 28M | -6.4M | -4.08M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -13.08M | -19.84M | -22.51M | -26.77M | -3.06M |
| Investing | 7.21M | 11.41M | 17.11M | 18.21M | -2k |
| Financing | 7.22M | 7.38M | 12.81M | 26.69M | -8.39M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -54.53M | -15.84M | -18.47M | -39.33M | -26.77M |
| Investing | -11k | -54.6M | 13.96M | 23.34M | 18.21M |
| Financing | 64.48M | 83.13M | -1.82M | 1.03M | 26.69M |
| Market Cap | 39.6M |
| Price to Earnings Ratio | -1.63 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.67 |
| Price to Book Ratio | -9.9 |
| Dividend Yield | - |
| Shares Outstanding | 40M |
| Average Volume (1 week) | 649.16k |
| Average Volume (1 Month) | 511.35k |
| 52 Week Change | -16.81% |
| 52 Week High | 3.02 |
| 52 Week Low | 0.808 |
| Spread (Intraday) | 0.07 (6.73%) |
| Company Name | Iterum Therapeutics PLC |
| Address |
200 s wacker drive chicago, illinois IL 60606 |
| Website | https://www.iterumtx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
